C-reactive protein to lymphocyte ratio as a new biomarker in predicting surgical site infection after posterior lumbar interbody fusion and instrumentation

被引:7
|
作者
Wu, Xiaofei [1 ]
Ma, Xun [1 ]
Zhu, Jian [1 ,2 ]
Chen, Chen [1 ]
机构
[1] Shanxi Med Univ, Shanxi Bethune Hosp, Hosp 3, Taiyuan, Peoples R China
[2] Hebei Med Univ, Hosp 3, Dept Orthopaed Surg, Shijiazhuang, Peoples R China
来源
FRONTIERS IN SURGERY | 2022年 / 9卷
关键词
posterior lumbar interbody fusion; perioperative management; risk prediction tool; creative protein to lymphocyte count ratio (CLR); surgical site infection; DEEP WOUND-INFECTION; INFLAMMATION; CRP/ALBUMIN; DIAGNOSIS; OUTCOMES; MARKER; HEALTH; LEVEL; COUNT;
D O I
10.3389/fsurg.2022.910222
中图分类号
R61 [外科手术学];
学科分类号
摘要
PurposeThis study aims to evaluate the potential of C-reactive protein to lymphocyte count ratio (CLR) for the prediction of surgical site infection (SSI) following posterior lumbar interbody fusion (PLIF) and the instrumentation of lumbar degenerative diseases. MethodsIn this retrospective study, we considered patients with a lumbar degenerative disease diagnosis surgically treated by the instrumented PLIF procedure from 2015 to 2021. Patient data, including postoperative early SSI and other perioperative variables, were collected from their respective hospitalization electronic medical records. The receiver operator characteristic curve was constructed to determine the optimal cut-off value for CLR, and the ability to predict SSI was evaluated by the area under the curve (AUC). According to the cut-off value, patients were dichotomized with high- or low-CLR, and between-group differences were compared using univariate analysis. The independent impact of CLR on predicting SSI was investigated by multivariate logistics regression analysis. ResultsA total of 773 patients were included, with 26 (3.4%) developing an early SSI post-operation. The preoperative CLR was 11.1 +/- 26.1 (interquartile range, 0.4-7.5), and the optimal cut-off was 2.1, corresponding to a sensitivity of 0.856, a specificity of 0.643, and an AUC of 0.768 (95% CI, 0.737-0.797). CLR demonstrated a significantly improved prediction ability than did lymphocyte count (P = 0.021) and a similar ability to predict an infection as C-response protein (P = 0.444). Patients with a high CLR had a significantly higher SSI incidence than those with a low CLR (7.6% vs. 0.8%, P < 0.001). After adjustment for numerous confounding factors, CLR >= 2.1 was associated with an 11.16-fold increased risk of SSI, along with other significant variables, i.e., diabetes, preoperative waiting time, and surgical duration. ConclusionA high CLR exhibited an improved ability to predict incident SSI and was associated with a substantially increased risk of SSI following instrumented PLIF. After better-design studies verified this finding, CLR could potentially be a beneficial tool in surgical management.
引用
收藏
页数:8
相关论文
共 50 条
  • [1] C-reactive protein to albumin ratio (CAR) in predicting surgical site infection (SSI) following instrumented posterior lumbar interbody fusion (PLIF)
    Qu, Shaozheng
    Sun, Mingchuan
    Sun, Hongliang
    Hu, Baiqiang
    INTERNATIONAL WOUND JOURNAL, 2023, 20 (01) : 92 - 99
  • [2] Surgical site infection after posterior lumbar interbody fusion and instrumentation in patients with lumbar degenerative disease
    Pei, Honglei
    Wang, Haiying
    Chen, Meiyun
    Ma, Lei
    Liu, Guobin
    Ding, Wenyuan
    INTERNATIONAL WOUND JOURNAL, 2021, 18 (05) : 608 - 615
  • [3] Treatment of Surgical Site Infection in Posterior Lumbar Interbody Fusion
    Lee, Jung Su
    Ahn, Dong Ki
    Chang, Byung Kwon
    Lee, Jae Il
    ASIAN SPINE JOURNAL, 2015, 9 (06) : 841 - 848
  • [4] Particular Features of Surgical Site Infection in Posterior Lumbar Interbody Fusion
    Kim, Jin Hak
    Ahn, Dong Ki
    Kim, Jin Woo
    Kim, Go We
    CLINICS IN ORTHOPEDIC SURGERY, 2015, 7 (03) : 337 - 343
  • [5] Incidence of Surgical Site Infection Following Lateral Lumbar Interbody Fusion Compared With Posterior/Transforaminal Lumbar Interbody Fusion A Propensity Score-Weighted Study
    Masuda, Soichiro
    Fukasawa, Toshiki
    Takeuchi, Masato
    Fujibayashi, Shunsuke
    Otsuki, Bungo
    Murata, Koichi
    Shimizu, Takayoshi
    Matsuda, Shuichi
    Kawakami, Koji
    SPINE, 2023, 48 (13) : 901 - 907
  • [6] Vancomycin Use in Posterior Lumbar Interbody Fusion of Deep Surgical Site Infection
    Wang, Shiyong
    Yao, Rubin
    Li, Zhongjie
    Gong, Xiangdong
    Xu, Jitao
    Yang, Fajun
    Yang, Kaishun
    INFECTION AND DRUG RESISTANCE, 2022, 15 : 3103 - 3109
  • [7] Treatment strategy for surgical site infection post posterior lumbar interbody fusion: A retrospective study
    Nakamura, Shigeko
    Nakai, Tsuyoshi
    Hosozawa, Koki
    Tanaka, Yudai
    Kishimoto, Koki
    Sakata, Kosuke
    Iwata, Hirokazu
    Okada, Seiji
    JOURNAL OF ORTHOPAEDICS, 2022, 31 : 40 - 44
  • [8] Role of Pre-Operative Nutrition Status on Surgical Site Infection After Posterior Lumbar Interbody Fusion: A Retrospective Study
    Yang, Yi-Fan
    Yu, Jun-Cheng
    Xiao, Zhen
    Kang, Yi-Jun
    Zhou, Bin
    SURGICAL INFECTIONS, 2023, 24 (10) : 942 - 948
  • [9] Lymphocyte C-reactive protein ratio: A new biomarker to predict early complications after gastrointestinal oncologic surgery
    Yildirim, Murat
    Koca, Bulent
    CANCER BIOMARKERS, 2021, 31 (04) : 409 - 417
  • [10] Lymphopenia and Elevated Blood C-Reactive Protein Levels at Four Days Postoperatively Are Useful Markers for Early Detection of Surgical Site Infection Following Posterior Lumbar Instrumentation Surgery
    Iwata, Eiichiro
    Shigematsu, Hideki
    Koizumi, Munehisa
    Nakajima, Hiroshi
    Okuda, Akinori
    Morimoto, Yasuhiko
    Masuda, Keisuke
    Tanaka, Yasuhito
    ASIAN SPINE JOURNAL, 2016, 10 (02) : 220 - 225